- Home
- MRNA vs NTAP Comparison
MRNA vs NTAP Comparison
Compare MRNA & NTAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | NTAP |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 19.7B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRNA | NTAP |
|---|---|---|
| Price | $49.11 | $103.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 13 |
| Target Price | $33.00 | ★ $118.25 |
| AVG Volume (30 Days) | ★ 7.1M | 1.7M |
| Earning Date | 04-30-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | 21.77 | ★ 22.46 |
| EPS | N/A | ★ 4.32 |
| Revenue | ★ $19,263,000,000.00 | $6,233,200,000.00 |
| Revenue This Year | $8.59 | $6.22 |
| Revenue Next Year | $16.72 | $4.91 |
| P/E Ratio | ★ N/A | $23.61 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $71.84 |
| 52 Week High | $59.55 | $126.66 |
Technical Indicators
Market Signals| Indicator | MRNA | NTAP |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 52.72 |
| Support Level | $48.09 | $101.76 |
| Resistance Level | $54.94 | $103.66 |
| Average True Range (ATR) | 2.63 | 3.09 |
| MACD | -0.77 | 0.11 |
| Stochastic Oscillator | 17.40 | 39.59 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NTAP NetApp Inc.
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).